Physician profile
Shane Tipton
NPI 1073977948
$26,714.64
in general payments reported to CMS, 2019-2025
11 companies · $1,791 in 2025
The $1,791 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $7,810 · 2022: $14K · 2023: $279 · 2024: $2,531 · 2025: $1,791.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,443 · Food and Beverage: $2,158.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,442.86 |
| Food and Beverage | $2,158.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $24,520.23 | 2021-2025 | Journey II, Legion Revision, Or3o Dual Mobility |
| Peerless Surgical INC. | $1,051.16 | 2023-2025 | |
| Stryker Corporation | $500.15 | 2022-2024 | Orthomap, T7, Triathlon |
| Arthrex, INC. | $244.20 | 2025 | |
| Bone Support INC. | $146.15 | 2025 | Ceramentbone Void Filler, Cerament G |
| Zimmer Biomet Holdings, INC. | $135.94 | 2021 | |
| Heraeus Medical, LLC. | $34.76 | 2024 | |
| Nuvasive, INC. | $29.94 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.41 | 2025 | Trintellix |
| Total Joint Orthopedics, INC. | $16.70 | 2021 | |
| Medical Device Business Services, INC. | $16.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shane Tipton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.